Vinodhini Kanakaraj

Vinodhini Kanakaraj

Auto-generated profile, based on publicly available information

Vinodhini Kanakaraj

Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology Avadi

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2026 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
UVUsha V
Usha V
SVSathya Velusamy
Sathya Velusamy
ATAnitha Thambiayyan
Anitha Thambiayyan
SSSathiya Priya Selvaraj
Sathiya Priya Selvaraj
VKVinodhini Kanakaraj
Vinodhini Kanakaraj
MCMadhumitha Chidambaram
Madhumitha Chidambaram
Early detection of Type 2 Diabetes (T2D) is perilous for remediating patient consequences and dropping long-term complications. This study proposes Scorpi-XStack, a diagnostic framework that integrates a novel bio-inspired optimization algorithm, ScorpiOpt, with stacked ensemble learning to enhance predictive accuracy. ScorpiOpt identifies the most discriminative clinical features by reducing redundancy and improving feature robustness. These selected features are used to train a weighted collaborative classifier containing Random Forest and XGBoost as ignoble learners, for which Logistic Regression is the master learner. The framework was validated on three benchmark datasets—Pima Indian Diabetes (Kaggle), clinical records from Medical City Hospital, Iraq (Mendeley Data), and the Frankfurt Diabetes dataset (GitHub/ResearchGate)—after applying ETL processing, mean/mode imputation for missing values, and z-score normalization. Classical recital remained assessed via stratiform 5-fold cross-validation, springy an accurateness of 98.54%, F1-score of 98.50%, balanced accuracy of 98.52% and AUROC of 99.86%. Compared with existing methods (85–95% accuracy range), Scorpi-XStack demonstrated consistent improvements across multiple performance metrics. While results are promising, limitations such as dataset heterogeneity, potential overfitting, and computational overhead should be noted. Further validation on larger, independent, and multi-center cohorts is necessary to confirm clinical applicability and generalizability.

1 August 2026
Verified
Conference Paper
Closed access
GSG. M. Sathyaseelan
G. M. Sathyaseelan
SPSANTHOSHKUMAR S P
SANTHOSHKUMAR S P
PMPreethi M
Preethi M
GSGajalakshmi S
Gajalakshmi S
VKVinodhini. K
Vinodhini. K
MRM. Rajalakshmi
M. Rajalakshmi

1 July 2026
Verified
Conference Paper
Closed access
KSKawsalya S
Kawsalya S
CLChristopher Joseph L
Christopher Joseph L
SPSANTHOSHKUMAR S P
SANTHOSHKUMAR S P
AKA. Kaliappan
A. Kaliappan
VKVinodhini. K
Vinodhini. K
SBS. Bindhu
S. Bindhu

1 July 2026
Verified
Conference Paper
Closed access
KSKawsalya S
Kawsalya S
SPSANTHOSHKUMAR S P
SANTHOSHKUMAR S P
PSP. Saravanabhava
P. Saravanabhava
LKL. Mohana Kannan
L. Mohana Kannan
VKVinodhini. K
Vinodhini. K
SBS. Bindhu
S. Bindhu

8 April 2026
Verified
Conference Paper
Closed access
SPSANTHOSHKUMAR S P
SANTHOSHKUMAR S P
SKSatyam Kumar
Satyam Kumar
KVK Vinodhini
K Vinodhini
SBS. Bindhu
S. Bindhu
SCSagarika Kar Chowdhury
Sagarika Kar Chowdhury
GSGajalakshmi S
Gajalakshmi S
Neurodegenerative disorders have a heterogeneous clinical presentation and the conventional diagnostic tools are not very sensitive thus making early detection of these disorders difficult. In this paper, an explainable multimodal deep learning model is proposed to identify and classify neurodegenerative diseases through early prediction and analysis of heterogeneous data, such as neuroimaging, speech signals, motor patterns, physiological biomarkers, genomic data and clinical metadata. Deep networks that are modality-specific are used in the extraction of robust features and advanced fusion mechanisms using attention to model cross-modal interactions and heterogeneity of features are addressed. The explainability-aware inference strategy offers clear understanding of the modality contributions and features relevance, which increases the clinical interpretability and trust. Substantial benchmark results indicate that the suggested framework has an excellent diagnostic accuracy, strong generalization, and better earlystage detection in comparison with the state-of-the-art methods. Findings make explainable multimodal deep learning a promising and scalable and reliable solution to early neurodegenerative disease detection and clinical decision support.

12 June 2026
Verified
Conference Paper
Closed access
SKS. Karthiyayini
S. Karthiyayini
BPB. Bala Vijaya Priya
B. Bala Vijaya Priya
TRTorthi Ravichandra
Torthi Ravichandra
SPSANTHOSHKUMAR S P
SANTHOSHKUMAR S P
VKVinodhini. K
Vinodhini. K
AKA. Kaliappan
A. Kaliappan